Venture Investment Management Company (VIMAC), a VC firm providing early-stage financing primarily to IT companies, was impacted by the decline in technology valuations in the early 2000’s
Primary program objective was to raise visibility for VIMAC to support fund raising efforts and attract high quality investments
And shift its positioning to include biotech and the overall medical technology sector
Strategy
Differentiate VIMAC by promoting its philosophy, culture and management and history
Position partners as experts/thought leaders in the IT industry
Generate high visibility in the bio/pharma/medical sector
Leverage PR to reach institutional and angel investors
Results
Generated substantial publicity in major business/financial and new economy media such as: Business Week, The Wall Street Journal, Forbes, Fortune, Reuters, InformationWeek, The Deal, enhancing VIMAC’s credibility
Which:
-Eased fund raising efforts by increasing visibility
-Helped differentiate VIMAC in crowded field of early-stage VC firms; worked as third-party endorsement for top-quality portfolio companies seeking a VC connection
-Established ongoing relationships for VIMAC with key reporters covering their space